5,478 UnitedHealth Group Incorporated $UNH Shares Bought by Sigma Investment Counselors Inc.

Sigma Investment Counselors Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 53.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,787 shares of the healthcare conglomerate’s stock after purchasing an additional 5,478 shares during the period. Sigma Investment Counselors Inc.’s holdings in UnitedHealth Group were worth $5,795,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Nvwm LLC grew its holdings in shares of UnitedHealth Group by 89.2% in the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 33 shares during the last quarter. Wellington Altus USA Inc. lifted its holdings in UnitedHealth Group by 97.1% during the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 33 shares in the last quarter. Security National Bank of SO Dak purchased a new stake in UnitedHealth Group in the 2nd quarter valued at about $29,000. Compass Wealth Management LLC bought a new position in UnitedHealth Group in the 3rd quarter worth about $29,000. Finally, Aberdeen Wealth Management LLC bought a new position in UnitedHealth Group in the 2nd quarter worth about $31,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $410.72 on Wednesday. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The firm has a 50-day simple moving average of $389.07 and a two-hundred day simple moving average of $361.44.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The firm had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. The firm’s quarterly revenue was down .4% on a year-over-year basis. During the same period in the previous year, the firm earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 20.62 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. BMO Capital Markets set a $512.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Royal Bank Of Canada boosted their price target on UnitedHealth Group from $478.00 to $498.00 and gave the company an “outperform” rating in a report on Tuesday, October 20th. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $370.00 to $467.00 and gave the stock a “hold” rating in a research note on Friday, July 17th. Evercore lifted their target price on UnitedHealth Group from $400.00 to $480.00 and gave the company an “outperform” rating in a research report on Tuesday, July 7th. Finally, Morgan Stanley upped their target price on UnitedHealth Group from $529.00 to $531.00 and gave the stock an “overweight” rating in a report on Tuesday. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $463.93.

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.